In vitro effects of vitamin C and selenium on NK activity of patients with β-thalassemia major

Pediatric Hematology and Oncology

Volumn 23, Issue 3, 2006, Pages 187-197

  Atasever, Belkis ^a   Ertan, Nesrin Zeynep ^a   Erdem Kuruca, Serap ^a   Karakas, Zeynep ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

thalassemia; Antioxidant; NK activity; Oxidative stress; Selenium; Vitamin C

Indexed keywords

ANTIOXIDANT; ASCORBIC ACID; S 1382; SELENIUM DERIVATIVE; SODIUM SELENIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BETA THALASSEMIA; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE FUNCTION; MINERAL INTAKE; NATURAL KILLER T CELL; SPLENECTOMY; VITAMIN INTAKE;

ADOLESCENT; ADULT; ANTIOXIDANTS; ASCORBIC ACID; BETA-THALASSEMIA; CELLS, CULTURED; CHILD; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; K562 CELLS; KILLER CELLS, NATURAL; MALE; SELENIUM; SPLENECTOMY;

EID: 33644845747     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010500506420     Document Type: Article

References (36)

1. Ezer U, Gulderen F, Culha VK, Akgul N. Immunological status of thalassemia syndrome. Pediatr Hematol Oncol. 2002;19:51-58.
2. Ho PJ, Thein SL. Gene regulation and deregulation: a β globin perspective. Blood Rev. 2000;14:78-93.
3. Hilliard LM, Berkow RL. The thalassemia syndromes. Prim Care Update Obstet Gynecol. 1996;3:157-162.
4. Giardina PJ, Hilgartner MW. Update on thalassemia. Pediatr Rev. 1992;13:55-63.
5. Rund D, Rachmilewitz E. New trends in the treatment of β-thalassemia. Crit Rev Oncol Hematol. 2000;33:105-118.
6. Wanachiwanawin W, Phucharoen J, Pattanapanyasat K, Fucharoen S, Webster HK. Lymphocytes in β-thalassemia/HbE: subpopulations and mitogen responses. Eur J Haematol. 1996;55:153-157.
7. Akbar AN, Fitzgerald-Bocarsly PA, De Sousa M, Giardina PJ, Hilgartner MW, Grady RW. Decreased natural killer activity in thalassemia major: a possible consequence of iron overload. J Immunol. 1986;136:1635-1640.
8. Farmakis D, Glakoumis A, Polymeropoulos E, Aessopos A. Pathogenetic aspects of immune deficiency associated with β thalassemia. Med Sci Monit. 2003;9:RA19-RA22.
9. Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release oxidative stress and erythrocyte ageing. Free Radic Biol Med. 2002;132:568-576.
10. Klingemann HG. Relevance and potential of natural killer cells in stem cell transplantation. Biol Blood Marrow Transplant. 2000:6:90-99.
11. Methenitou G, Maravelias C, Athanaselis S, Dona A, Koutselinis A. Immunomodulative effects of aflatoxins and selenium on human natural killer cells. Vet Hum Toxicol. 2001;43:232-234.
12. Carr AC, Tijerina T, Frei B. Vitamin C protects against and reverses specific hypochlorous acid- and chloramine-dependent modifications of low-density lipoprotein. Biochem J. 2000;348:491-499.
13. Navarro-Alarcon M, Lopez-Martinez MC. Essentially of selenium in the human body: relationship with different diseases. Sci Total Environ. 2000;249:347-371.
14. Ferrandez MD, Correa R, Del Rio M, De la Fuente M. Effects in vitro of several antioxidants on the natural killer function of aging mice. Exp Gerontol. 1999;34:675-685.
15. Vojdani A, Namatalla G. Enhancement of human natural killer cytotoxic activity by vitamin C in pure and augmented formulations. J Nutr Environ Med. 1997;7:187-195.
16. Vinceti M, Wei ET, Malagoli C, Bergomi M, Vivoli G. Adverse health effects of selenium in humans. Rev Environ Health. 2001;16:233-251.
17. Wood SM, Beckham C, Yosioka A, Darban H, Watson RR. β-Carotene and selenium supplementation enhances immune response in aged humans. Integrative Med. 2000;2:85-92.
18. Huwyler T, Hirt A, Morell A. Effect of ascorbic acid on human natural killer cells. Immunol Lett. 1982;10:173-176.
19. Halliwell B. The antioxidant paradox. Lancet. 2000;355:1179-1180.
20. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55-63.
21. Schlager SI, Adams AC. Use of dyes and radioisotopic markers in cytotoxicity tests. Methods Enzymol. 1983;93:233-245.
22. Consolini R, Calleri A, Legitimo A, Massei F. Immunological evaluation of patients with beta-thalassemia major. Acta Haematol. 2001;105:7-12.
23. Pattanapanyasat K, Thepthai C, Lamchiagdhase P, et al. Lymphocyte subsets and spesific T-cell immune response in thalassemia. Commun Clin Cytometry. 2000;42:11-17.
24. Walker EM, Walker SM. Review: effects of iron overload on the immune system. Ann Clin Lab Sci. 2000;30:354-365.
25. Jakobisiak M, Lasek W, Golab J. Natural mechanisms protecting against cancer. Immunol Lett. 2003;90:103-122.
26. Bartfay WJ, Bartlay E. Selenium and glutathione peroxidase with beta-thalassemia major. Nurs Res. 2001;50:178-183.
27. Winterbourn CC, Kettle AJ. Radical-radical reactions of superoxide: a potential route toxicity. Biochem Biophs Res Commun. 2003;305:729-736.
28. Meeker HC, Eskew ML, Scheuchenzuber W, Scholz RW, Zarkower A. Antioxidant effects on cell-mediated immunity. J Leukoc Biol. 1985;38:451-458.
29. Dhur A, Galan P, Hercberg S. Relationship between selenium, immunity and resistance against infection. Comp Biochem Physiol. 1990;96:271-280.
30. Stewart MS, Spallholz JE., Neldner KH, Pence BC. Selenium compounds have disparate abilities to impose oxidative stress and induce apoptosis. Free Radic Biol Med. 1999;26:42-48.
31. Cemeli E, Carder J, Anderson D, et al. Antigenotoxic properties of selenium compounds on potassium dichromate and hydrogen peroxide. Teratog Carcinog Mutagen. 2003;2:53-67.
32. Spallholz JE. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed Environ Sci. 1997;10:260-270.
33. Nielsen HB, Secher NH, Kristensen JH, Christensen NJ, Espersen K, Pedersen BK. Splenectomy impairs lymphocytosis during maximal exercise. Am J Physiol. 1997;272:R1847-R1852.
34. Gerster H. High-dose vitamin C: a risk for persons with high iron stores? Int J Vit Nutr Res. 1999;69:67-82.
35. Vojdani A, Ghoneum M. In vivo effect of ascorbic acid on enhancement of human natural killer cell activity. Nutr Res. 1993;13:753-764.
36. Chen K, Suh J, Carr AC, Marrow JD, Zeind J, Frei B. Vitamin C suppresses oxidative lipid damage in vivo, even in the presence of iron overload. Am J Physiol Endocrinol Metab. 2000;279:E1406-E1412.